Getinge Future Growth
Future criteria checks 3/6
Getinge is forecast to grow earnings and revenue by 22% and 5.8% per annum respectively. EPS is expected to grow by 21.6% per annum. Return on equity is forecast to be 10.4% in 3 years.
Key information
22.0%
Earnings growth rate
21.6%
EPS growth rate
Medical Equipment earnings growth | 17.1% |
Revenue growth rate | 5.8% |
Future return on equity | 10.4% |
Analyst coverage | Good |
Last updated | 15 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 38,026 | 3,386 | 3,711 | 5,151 | 9 |
12/31/2025 | 36,191 | 2,925 | 3,198 | 4,567 | 9 |
12/31/2024 | 34,171 | 2,059 | 2,817 | 4,441 | 9 |
9/30/2024 | 33,591 | 1,691 | 2,566 | 3,862 | N/A |
6/30/2024 | 33,328 | 2,584 | 3,279 | 4,593 | N/A |
3/31/2024 | 32,199 | 2,285 | 3,263 | 4,633 | N/A |
12/31/2023 | 31,827 | 2,412 | 1,604 | 2,957 | N/A |
9/30/2023 | 30,423 | 2,251 | 1,320 | 2,654 | N/A |
6/30/2023 | 29,756 | 2,154 | 1,252 | 2,519 | N/A |
3/31/2023 | 29,251 | 2,543 | 1,105 | 2,293 | N/A |
12/31/2022 | 28,292 | 2,491 | 2,231 | 3,367 | N/A |
9/30/2022 | 27,781 | 2,707 | 2,835 | 3,916 | N/A |
6/30/2022 | 27,146 | 2,665 | 3,085 | 4,135 | N/A |
3/31/2022 | 27,062 | 2,860 | 4,188 | 5,173 | N/A |
12/31/2021 | 27,049 | 2,970 | 5,630 | 6,560 | N/A |
9/30/2021 | 27,900 | 3,292 | 6,585 | 7,533 | N/A |
6/30/2021 | 29,571 | 3,916 | 6,893 | 7,811 | N/A |
3/31/2021 | 29,955 | 3,612 | 7,021 | 7,988 | N/A |
12/31/2020 | 29,819 | 3,239 | 6,154 | 7,199 | N/A |
9/30/2020 | 29,478 | 3,050 | 5,218 | 6,336 | N/A |
6/30/2020 | 27,738 | 1,878 | 4,239 | 5,437 | N/A |
3/31/2020 | 27,044 | 1,487 | 3,461 | 4,690 | N/A |
12/31/2019 | 26,559 | 1,222 | 2,612 | 3,832 | N/A |
9/30/2019 | 25,951 | 1,030 | 1,595 | 2,836 | N/A |
6/30/2019 | 25,398 | -632 | 1,811 | 3,082 | N/A |
3/31/2019 | 24,852 | -654 | 1,259 | 2,592 | N/A |
12/31/2018 | 24,172 | -967 | 1,123 | 2,503 | N/A |
9/30/2018 | 23,653 | -727 | 1,425 | 2,899 | N/A |
6/30/2018 | 22,914 | 847 | N/A | 2,371 | N/A |
3/31/2018 | 22,552 | 676 | N/A | 2,193 | N/A |
12/31/2017 | 22,495 | 1,096 | N/A | 2,763 | N/A |
9/30/2017 | 17,061 | 596 | N/A | 3,466 | N/A |
6/30/2017 | 19,046 | 390 | N/A | 3,599 | N/A |
3/31/2017 | 20,604 | 701 | N/A | 3,839 | N/A |
12/31/2016 | 22,170 | 698 | N/A | 3,671 | N/A |
9/30/2016 | 29,650 | 1,203 | N/A | 3,372 | N/A |
6/30/2016 | 29,646 | 1,462 | N/A | 3,369 | N/A |
3/31/2016 | 29,900 | 1,410 | N/A | 3,504 | N/A |
12/31/2015 | 30,235 | 1,390 | N/A | 3,458 | N/A |
9/30/2015 | 29,303 | 1,429 | N/A | 3,366 | N/A |
6/30/2015 | 28,603 | 1,622 | N/A | 3,386 | N/A |
3/31/2015 | 27,749 | 1,850 | N/A | 3,689 | N/A |
12/31/2014 | 26,669 | 1,433 | N/A | 3,473 | N/A |
9/30/2014 | 25,843 | 1,672 | N/A | 3,491 | N/A |
6/30/2014 | 25,468 | 1,718 | N/A | 3,674 | N/A |
3/31/2014 | 25,157 | 1,776 | N/A | 3,616 | N/A |
12/31/2013 | 25,287 | 2,285 | N/A | 3,544 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GNGB.Y's forecast earnings growth (22% per year) is above the savings rate (2.6%).
Earnings vs Market: GNGB.Y's earnings (22% per year) are forecast to grow faster than the US market (15.3% per year).
High Growth Earnings: GNGB.Y's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: GNGB.Y's revenue (5.8% per year) is forecast to grow slower than the US market (8.9% per year).
High Growth Revenue: GNGB.Y's revenue (5.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: GNGB.Y's Return on Equity is forecast to be low in 3 years time (10.4%).